177 related articles for article (PubMed ID: 30834560)
1. Pediatric toxic epidermal necrolysis treated successfully with infliximab.
Chafranska L; Saunte DM; Behrendt N; Nygaard U; Christensen RJ; Sand C; Jemec GB
Pediatr Dermatol; 2019 May; 36(3):342-345. PubMed ID: 30834560
[TBL] [Abstract][Full Text] [Related]
2. Use of infliximab in toxic epidermal necrolysis: a still opened challenge.
Ganzetti G; Campanati A; Simonetti O; Giuliodori K; Giangiacomi M; Lemme G; Offidani A
G Ital Dermatol Venereol; 2015 Aug; 150(4):467-71. PubMed ID: 25394212
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam-induced pediatric toxic epidermal necrolysis successfully treated with etanercept.
Estébanez A; Sáez-Martín LC; Muñoz JI; Silva E; Monrabal A; Monteagudo C; Ramón MD
Pediatr Dermatol; 2020 Jul; 37(4):701-705. PubMed ID: 32319121
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha inhibitors in the treatment of toxic epidermal necrolysis.
Woolridge KF; Boler PL; Lee BD
Cutis; 2018 Jan; 101(1):E15-E21. PubMed ID: 29529123
[TBL] [Abstract][Full Text] [Related]
5. Etoricoxib-induced toxic epidermal necrolysis: successful treatment with infliximab.
Kreft B; Wohlrab J; Bramsiepe I; Eismann R; Winkler M; Marsch WC
J Dermatol; 2010 Oct; 37(10):904-6. PubMed ID: 20860742
[No Abstract] [Full Text] [Related]
6. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
[TBL] [Abstract][Full Text] [Related]
7. Toxic Epidermal Necrolysis from suspected Mycoplasma pneumoniae infection.
McDermott AJ; Taylor BM; Bernstein KM
Mil Med; 2013 Sep; 178(9):e1048-50. PubMed ID: 24005558
[TBL] [Abstract][Full Text] [Related]
8. Toxic epidermal necrolysis in a child successfully treated with infliximab.
Scott-Lang V; Tidman M; McKay D
Pediatr Dermatol; 2014; 31(4):532-4. PubMed ID: 23072342
[TBL] [Abstract][Full Text] [Related]
9. Mycoplasma pneumoniae-induced recurrent Stevens-Johnson syndrome in children: a case report.
Campagna C; Tassinari D; Neri I; Bernardi F
Pediatr Dermatol; 2013; 30(5):624-6. PubMed ID: 24016288
[TBL] [Abstract][Full Text] [Related]
10. Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study.
Paquet P; Jennes S; Rousseau AF; Libon F; Delvenne P; Piérard GE
Burns; 2014 Dec; 40(8):1707-12. PubMed ID: 24726294
[TBL] [Abstract][Full Text] [Related]
11. Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis.
Fischer M; Fiedler E; Marsch WC; Wohlrab J
Br J Dermatol; 2002 Apr; 146(4):707-9. PubMed ID: 11966713
[No Abstract] [Full Text] [Related]
12. Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.
Gavigan GM; Kanigsberg ND; Ramien ML
J Cutan Med Surg; 2018; 22(5):514-515. PubMed ID: 29421925
[TBL] [Abstract][Full Text] [Related]
13. Extensive hypertrophic scarring after toxic epidermal necrolysis in a child.
Kreft B; Lieser U; Haase R; Marsch WC; Wohlrab J
Pediatr Dermatol; 2014; 31(4):527-8. PubMed ID: 23025572
[TBL] [Abstract][Full Text] [Related]
14. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
15. Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a systemic review.
Zhang S; Tang S; Li S; Pan Y; Ding Y
J Dermatolog Treat; 2020 Feb; 31(1):66-73. PubMed ID: 30702955
[No Abstract] [Full Text] [Related]
16. FR-Ciclosporin as a First-Line Treatment in Epidermal Necrolysis.
Morgado-sCarrasco D; Fustà-Novell X; Iranzo P
Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):601-603. PubMed ID: 30971332
[No Abstract] [Full Text] [Related]
17. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA
J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide in toxic epidermal necrolysis.
Levy R
Lancet; 1999 Jan; 353(9149):324. PubMed ID: 9929048
[No Abstract] [Full Text] [Related]
19. A case report of Stevens-Johnson syndrome with Mycoplasma pneumoniae infection.
Saitoh A; Ohya T; Yoshida S; Hosoya R; Nishimura K
Acta Paediatr Jpn; 1995 Feb; 37(1):113-5. PubMed ID: 7754754
[TBL] [Abstract][Full Text] [Related]
20. Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome: a case series.
Ravin KA; Rappaport LD; Zuckerbraun NS; Wadowsky RM; Wald ER; Michaels MM
Pediatrics; 2007 Apr; 119(4):e1002-5. PubMed ID: 17353300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
